Clinical and Experimental Metastasis
Publication Venue For
Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1.
Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example.
Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
MTBP inhibits migration and metastasis of hepatocellular carcinoma.
Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis.
Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.
FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.
NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma.
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.
CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell-like properties and correlate to survival.
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.
KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.
BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice.
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma.
Multi-faceted role of HSP40 in cancer.
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.
Syndecan-1: a dynamic regulator of the myeloma microenvironment.
Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.
Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
A novel assay for the quantification of invasion from raft cultures of lung carcinomas.
A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.
Breast cancer metastasis suppressor 1: update.
Clinical & Experimental Metastasis: Introduction
Clinical and Experimental Metastasis: Introduction
Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice.
KISS1 metastasis suppression and emergent pathways.
MDA-MB-435 human breast carcinoma metastasis to bone.
The skeleton as a unique environment for breast cancer cells.
B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy.
Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells.
Analysis of mechanisms underlying BRMS1 suppression of metastasis.
Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.
Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).
Technical considerations for studying cancer metastasis in vivo.
Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.
U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis.
Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.
A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity.
Implications of tumor progression on clinical oncology.
Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials.
Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties.
Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR.
Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)